TrialAntimicrobial agents and chemotherapy2004

Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

Jeffrey M Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.